BionicM appoints Mutsuki Takano as CFO and COO
BionicM appointed Mutsuki Takano as executive officer, chief financial officer and chief operating officer.
Evidence notes
- Takano previously served as board director and CFO of Heartseed and led the company through its July 2024 Tokyo Stock Exchange Growth Market IPO.
- His prior work spans Mitsui & Co., venture-capital investment and management support for biotechnology companies.
- BionicM says he has led equity financings totalling approximately ¥15 billion across his career.
Company overview
BionicM develops Bio Leg, a powered microprocessor knee for transfemoral amputees. The University of Tokyo spin-out combines motorized assistance, onboard sensing and movement control to support standing, walking and stair use. U.S. sales began in 2024, and the company completed its first customer deliveries that August.